Medical Research Council
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1913-01-01
- Employees
- -
- Market Cap
- -
Novel Blood Test Could Guide Precision Treatment for Resistant Lupus with Rituximab-Belimumab Combination
A £1.7 million clinical trial called "Stratify Lupus" will test if a blood biomarker (IgA2 anti-dsDNA) can identify lupus patients who would respond to a novel combination of rituximab and belimumab.
UK Dementia Trials Accelerator Aims to Radically Increase Clinical Trial Participation
The Dementia Trials Accelerator will receive £20m in government funding to significantly increase UK participation in dementia clinical trials.
Transdermal Estradiol Shows Promise as Alternative to LHRH Agonists in High-Risk Prostate Cancer
A phase 3 study presented at ESMO 2024 indicates transdermal estradiol (tE2) is as effective as LHRH agonists for androgen suppression in high-risk, non-metastatic prostate cancer.
Behavioral Science Emerges as Key Strategy for Driving Adoption of Novel Therapies in Biopharma
Pharmaceutical companies are increasingly turning to behavioral science principles to overcome barriers in prescribing patterns and drive adoption of new therapies, moving beyond traditional educational approaches.
Rare Disease Research Faces Critical Funding Gap Despite Scientific Value
Major UK medical research funders allocate less than 1% of their budgets to rare disease research, despite these conditions consuming 10% of the NHS specialized services budget.
Global Push for Clinical Trial Transparency Gains Momentum with EMA and AllTrials Campaign
The European Medicines Agency has committed to proactive publication of clinical trial data starting January 2014, enabling independent analysis of evidence used for drug approvals.